Will Fewer PSA Screenings Lead To More Prostate Cancer Deaths?

Will Fewer PSA Screenings Lead To More Prostate Cancer Deaths?
Two recent studies revealed that fewer men are undergoing PSA tests, which raises the question: Will there be more men dying from prostate cancer in the future as a result? In a 2015 news release, Dr. David Samadi, chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York, said that despite efforts to push

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , .

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

One comment

  1. Chris O'Neill says:

    “The evidence remains that since PSA screening became widely recognized in the early 1990s, there has been a 39 percent reduction in prostate cancer mortality rates,” Samadi said in the release.”

    This is not evidence that PSA screening saves lives or even lives from prostate cancer mortality. Observational correlation is not proof of cause. There can be many reasons for change in prostate death rate over time. The only way to prove cause is with a controlled trial, and none of the controlled trials have shown any overall survival benefit from PSA screening compared with usual care.

Leave a Comment

Your email address will not be published. Required fields are marked *